Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis

被引：1
|
作者：
Freemantle, N. [1 ]
Piketty, C. [2 ]
机构：
[1] UCL, Inst Clin Trials & Methodol, London, England
[2] Galderma, Lausanne, Switzerland
来源：
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY | 2021年 / 31卷 / 06期
关键词：
Nemolizumab; Adult atopic dermatitis;
D O I：
10.18176/jiaci.0727
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：528 / 529
页数：2
相关论文
共 50 条
  • [1] A Reply to "Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis"
    Lin, L.
    Han, Y.
    [J]. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2021, 31 (06) : 529 - 530
  • [2] Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis: A Meta-analysis of Randomized Clinical Trials
    Xiao, X.
    Lin, L.
    Zhu, C.
    Yang, X.
    Ni, Y.
    Zhipeng, L.
    Chong, J.
    Han, Y.
    [J]. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2021, 31 (02) : 190 - 192
  • [3] The role of nemolizumab in the treatment of atopic dermatitis for the adult population
    Prajapati, Stuti
    Flemming, Joseph P.
    Khan, Danyaal
    Han, Haowei
    How, Brian
    Rozenberg, Suzanne Sirota
    Feldman, Steven R.
    [J]. IMMUNOTHERAPY, 2024,
  • [4] Study of nemolizumab pharmacokinetics, safety, and efficacy in adolescents with atopic dermatitis
    Sidbury, Robert
    Alpizar, Sady
    Laquer, Vivian
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB114 - AB114
  • [5] Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in Adolescents
    Sidbury, Robert
    Alpizar, Sady
    Laquer, Vivian
    Dhawan, Sunil
    Abramovits, William
    Loprete, Luca
    Krishnaswamy, Jayendar Kumar
    Ahmad, Faiz
    Jabbar-Lopez, Zarif
    Piketty, Christophe
    [J]. DERMATOLOGY AND THERAPY, 2022, 12 (03) : 631 - 642
  • [6] Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in Adolescents
    Robert Sidbury
    Sady Alpizar
    Vivian Laquer
    Sunil Dhawan
    William Abramovits
    Luca Loprete
    Jayendar Kumar Krishnaswamy
    Faiz Ahmad
    Zarif Jabbar-Lopez
    Christophe Piketty
    [J]. Dermatology and Therapy, 2022, 12 : 631 - 642
  • [7] Nemolizumab for atopic dermatitis
    Labib, Angelina
    Vander Does, Ashley
    Yosipovitch, Gil
    [J]. DRUGS OF TODAY, 2022, 58 (04) : 159 - 173
  • [8] Efficacy of nemolizumab in atopic dermatitis: Rapid impact on EASI and SCORAD components
    Bouaziz, Jean-David
    Pinter, Andreas
    Alavi, Afsaneh
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB53 - AB53
  • [9] Evaluation of safety and efficacy of Dermaveel in treatment of atopic dermatitis
    Wilkowska, Aleksandra
    Grubska-Suchanek, Elzbieta
    Nowicki, Roman
    [J]. ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY, 2015, 2 (04) : 128 - 133
  • [10] New Biologics for the Treatment of Atopic Dermatitis: Analysis of Efficacy, Safety, and Paradoxical Atopic Dermatitis Acceleration
    Qi, Hong-jiao
    Li, Lin-Feng
    [J]. BIOMED RESEARCH INTERNATIONAL, 2021, 2021
12345